Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · IEX Real-Time Price · USD
0.790
+0.015 (1.95%)
At close: Apr 24, 2024, 4:00 PM
0.751
-0.040 (-5.01%)
After-hours: Apr 24, 2024, 7:38 PM EDT

Tiziana Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20222021202020192018
Market Capitalization
79619313874105
Market Cap Growth
--34.47%-32.32%87.30%-29.64%-
Enterprise Value
624351737499
PE Ratio
-3.97-3.97-3.99-5.28-7.90-13.20
PB Ratio
4.063.132.262.21-13.36201.80
P/FCF Ratio
-3.12-3.12-4.29-12.17-10.84-22.76
P/OCF Ratio
-3.12-3.12-4.29-12.18-10.84-22.76
EV/EBITDA Ratio
-2.83-2.83-1.94-2.62-7.69-10.09
EV/EBIT Ratio
-2.82-2.82-1.93-2.61-7.49-10.08
EV/FCF Ratio
-2.22-2.22-2.35-6.45-10.93-21.61
Debt / Equity Ratio
0.020.02-0.01-0.15-
Debt / EBITDA Ratio
-0.02-0.02--0.03-0.08-
Debt / FCF Ratio
-0.02-0.02--0.08-0.12-
Quick Ratio
3.013.015.828.410.130.92
Current Ratio
3.643.646.458.790.211.08
Interest Coverage
-2198.57-2198.57-150.46-89.83-109.02-822.25
Return on Equity (ROE)
-50.60%-50.60%-45.20%-91.90%373.30%902.10%
Return on Assets (ROA)
-40.90%-40.90%-39.20%-71.60%-200.50%-169.00%
Return on Capital (ROIC)
-73.16%-73.16%-66.31%-44.30%211.35%-1901.16%
Earnings Yield
-19.37%-25.15%-25.07%-18.93%-12.65%-7.58%
FCF Yield
-24.68%-32.05%-23.32%-8.21%-9.23%-4.39%
Buyback Yield / Dilution
-5.10%-5.10%-42.41%-0.14%2.93%-
Total Shareholder Return
-5.10%-5.10%-42.41%-0.14%2.93%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).